Overview Statistic: PDF-Downloads (blue) and Frontdoor-Views (gray)
  • Treffer 3 von 7
Zurück zur Trefferliste

Influenza and other respiratory viruses: standardizing disease severity in surveillance and clinical trials

  • Introduction: Influenza-Like Illness is a leading cause of hospitalization in children. Disease burden due to influenza and other respiratory viral infections is reported on a population level, but clinical scores measuring individual changes in disease severity are urgently needed. Areas covered: We present a composite clinical score allowing individual patient data analyses of disease severity based on systematic literature review and WHO-criteria for uncomplicated and complicated disease. The 22-item ViVI Disease Severity Score showed a normal distribution in a pediatric cohort of 6073 children aged 0–18 years (mean age 3.13; S.D. 3.89; range: 0 to 18.79). Expert commentary: The ViVI Score was correlated with risk of antibiotic use as well as need for hospitalization and intensive care. The ViVI Score was used to track children with influenza, respiratory syncytial virus, human metapneumovirus, human rhinovirus, and adenovirus infections and is fully compliant with regulatory data standards. The ViVI Disease Severity Score mobile application allows physicians to measure disease severity at the point-of care thereby taking clinical trials to the next level.

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Verfasserangaben:Barbara Rath, Tim ConradORCiD, Puja Myles, Maren Alchikh, Xiaolin Ma, Christian Hoppe, Franziska Tief, Xi Chen, Patrick Obermeier, Bron Kisler, Brunhilde Schweiger
Dokumentart:Artikel
Titel des übergeordneten Werkes (Englisch):Expert Review of Anti-infective Therapy
Band:15
Ausgabe / Heft:6
Erste Seite:545
Letzte Seite:568
Freies Schlagwort / Tag:Disease severity; adenovirus; antivirals; clinical trials; human metapneumovirus; human rhinovirus; influenza; influenza-like illness; respiratory syncytial virus; seasonality
Jahr der Erstveröffentlichung:2017
DOI:https://doi.org/10.1080/14787210.2017.1295847
Accept ✔
Diese Webseite verwendet technisch erforderliche Session-Cookies. Durch die weitere Nutzung der Webseite stimmen Sie diesem zu. Unsere Datenschutzerklärung finden Sie hier.